HVO Hvivo Plc

TIDMVENN

RNS Number : 8246C

Venn Life Sciences Holdings PLC

30 June 2016

Venn Life Sciences Holdings Plc

("Venn" or the "Company")

Result of AGM

Venn Life Sciences (AIM: VENN), a growing Contract Research Organisation providing drug development, clinical trial management and resourcing solutions to pharmaceutical, biotechnology and medical device clients, announces that at its Annual General Meeting held earlier today, all resolutions were duly passed.

Enquiries:

 
Venn Life Sciences Holdings Plc                                     www.vennlifesciences.com 
Tony Richardson, Chief Executive Officer                                Tel: +353 154 99 341 
Jonathan Hartshorn, Chief Financial Officer                             Tel: +353 153 93 269 
Aoife O Farrell, Marketing Manager                                      Tel: +353 153 93 269 
 
Davy (Nominated Adviser, ESM Adviser and                                Tel: +353 1 679 6363 
 Joint Broker) 
Fergal Meegan / Matthew DeVere White (Corporate 
 Finance) 
Paul Burke (Corporate Broking) 
 
Hybridan LLP (Joint-Broker) 
Claire Louise Noyce                                                       Tel: 020 3764 2341 
 
Walbrook PR Ltd                                    Tel: 020 7933 8787 or venn@walbrookpr.com 
Paul McManus                                                              Mob: 07980 541 893 
Lianne Cawthorne                                                          Mob: 07584 391 303 
 
 

About Venn Life Sciences Limited: Venn Life Sciences is a Contract Research Organisation providing drug development, clinical trial management and resourcing solutions to pharmaceutical, biotechnology and medical device organisations. With dedicated operations in France, Germany, the Netherlands, the UK, Ireland and Europe wide representation - Venn Life Sciences specialises in rapid deployment and management of multisite projects, across all phases. Venn Life Sciences also has an innovation division - Innovenn - focused primarily on breakthrough development opportunities in Skin Science.

For more information about the Company, please visit: www.vennlifesciences.com

This information is provided by RNS

The company news service from the London Stock Exchange

END

RAGURAARNNANOAR

(END) Dow Jones Newswires

June 30, 2016 07:18 ET (11:18 GMT)

Hvivo (LSE:HVO)
Graphique Historique de l'Action
De Juin 2024 à Juil 2024

Hvivo (LSE:HVO)
Graphique Historique de l'Action
De Juil 2023 à Juil 2024